These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
166 related articles for article (PubMed ID: 17042081)
1. Addressing the threat of tuberculosis caused by extensively drug-resistant Mycobacterium tuberculosis. Wkly Epidemiol Rec; 2006 Oct; 81(41):386-90. PubMed ID: 17042081 [No Abstract] [Full Text] [Related]
2. Southern Africa is moving swiftly to combat the threat of XDR-TB. Wise J Bull World Health Organ; 2006 Dec; 84(12):924-5. PubMed ID: 17242824 [No Abstract] [Full Text] [Related]
3. XDR-TB or not XDR-TB? That is the question. Bateman C S Afr Med J; 2007 May; 97(5):318, 320, 322. PubMed ID: 17599208 [No Abstract] [Full Text] [Related]
4. Living the TB resistance nightmare. Bateman C S Afr Med J; 2006 Oct; 96(10):1014-6. PubMed ID: 17164928 [No Abstract] [Full Text] [Related]
6. WHO's 2013 global report on tuberculosis: successes, threats, and opportunities. Zumla A; George A; Sharma V; Herbert N; Baroness Masham of Ilton Lancet; 2013 Nov; 382(9907):1765-7. PubMed ID: 24269294 [No Abstract] [Full Text] [Related]
7. The worldwide epidemic of multidrug-resistant tuberculosis. The Lancet Infectious Diseases Lancet Infect Dis; 2011 May; 11(5):333. PubMed ID: 21530885 [No Abstract] [Full Text] [Related]
8. Tuberculosis control goals unlikely to be met by 2005. Sharma DC Lancet; 2004 Apr; 363(9415):1122. PubMed ID: 15068013 [No Abstract] [Full Text] [Related]
11. Carpe diem ('Seize the day'): Building on the findings of the 2015 World Health Organization evaluation of the multidrug-resistant tuberculosis (MDR-TB) programme to make the most of shortened MDR-TB treatment in South Africa. Loveday M; Cox H S Afr Med J; 2017 Feb; 107(3):176-177. PubMed ID: 28281418 [No Abstract] [Full Text] [Related]
12. Progress towards achieving global tuberculosis control: so near, yet so far. Zumla A; Davies PD Int J Tuberc Lung Dis; 2016 Mar; 20(3):285-6. PubMed ID: 27046703 [No Abstract] [Full Text] [Related]
13. Drug-resistant tuberculosis: reality and potential threat. Lalloo UG Int J Tuberc Lung Dis; 2010 Mar; 14(3):255-8. PubMed ID: 20132610 [No Abstract] [Full Text] [Related]
14. [Extensively drug resistant and extremely drug resistant tuberculosis forms after multi-drug resistant tuberculosis: new faces of the old disease]. Baylan O Mikrobiyol Bul; 2011 Jan; 45(1):181-95. PubMed ID: 21341173 [TBL] [Abstract][Full Text] [Related]
15. Drug-resistant tuberculosis--current dilemmas, unanswered questions, challenges, and priority needs. Zumla A; Abubakar I; Raviglione M; Hoelscher M; Ditiu L; McHugh TD; Squire SB; Cox H; Ford N; McNerney R; Marais B; Grobusch M; Lawn SD; Migliori GB; Mwaba P; O'Grady J; Pletschette M; Ramsay A; Chakaya J; Schito M; Swaminathan S; Memish Z; Maeurer M; Atun R J Infect Dis; 2012 May; 205 Suppl 2():S228-40. PubMed ID: 22476720 [TBL] [Abstract][Full Text] [Related]
16. Tuberculosis in migrants from 106 countries to Italy, 2008-2014. Fattorini L; Mustazzolu A; Borroni E; Piccaro G; Giannoni F; Cirillo DM; Eur Respir J; 2016 Apr; 47(4):1273-6. PubMed ID: 26846829 [No Abstract] [Full Text] [Related]
19. Emergence and treatment of multidrug resistant (MDR) and extensively drug-resistant (XDR) tuberculosis in South Africa. Streicher EM; Müller B; Chihota V; Mlambo C; Tait M; Pillay M; Trollip A; Hoek KG; Sirgel FA; Gey van Pittius NC; van Helden PD; Victor TC; Warren RM Infect Genet Evol; 2012 Jun; 12(4):686-94. PubMed ID: 21839855 [TBL] [Abstract][Full Text] [Related]
20. [Extremely resistant tuberculosis in Africa. The Danish Society for Tropical Medicine and International Health]. Ravn P; Vestergaard LS; David KP; Ugeskr Laeger; 2007 Mar; 169(12):1135. PubMed ID: 17394846 [No Abstract] [Full Text] [Related] [Next] [New Search]